 Extracellular vesicles, EVs, such as exosomes and micro vesicles, are small membrane bound particles secreted by all types of cells. These vesicles contain a variety of molecules including proteins, RNA, and DNA, and can be used as vehicles for delivering drugs or genetic material into cells. Due to their unique characteristics, EVs have become increasingly important in the development of new therapies for treating diseases such as cancer and neurodegenerative disorders. In particular, during the COVID-19 pandemic, EVs have been explored as potential carriers for delivering antiviral drugs and vaccine components. This review summarizes the current knowledge about the use of EVs in the treatment of COVID-19, with emphasis on the advantages and limitations of this approach. This article was authored by Peng Soo, Yu Chen Wu, Feng Xia, and others. We are article.tv, links in the description below.